Skip to content
  • Home
  • About Us
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Technology
  • Pipeline
    • Osteoporosis
    • Hypoparathyroidism
    • SBS & Obesity
    • Publications
  • Investors
    • Share Information
      • Share Chart
    • Email Alerts
    • Press Releases
    • SEC Filing
    • Investor Calendar
    • Corporate Governance
      • Board of Directors
      • Management
      • Committee Composition
    • Investor Resources
      • Investor FAQs
      • Document Request
      • Email Alerts
    • Corporate Presentation
  • Contact Us
  • Home
  • About Us
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Technology
  • Pipeline
    • Osteoporosis
    • Hypoparathyroidism
    • SBS & Obesity
    • Publications
  • Investors
    • Share Information
      • Share Chart
    • Email Alerts
    • Press Releases
    • SEC Filing
    • Investor Calendar
    • Corporate Governance
      • Board of Directors
      • Management
      • Committee Composition
    • Investor Resources
      • Investor FAQs
      • Document Request
      • Email Alerts
    • Corporate Presentation
  • Contact Us

Publications

Home » Publications

Osteoporosis

  • 2024 ASBMR Poster
  • 2024 JBMR Editorial
  • 2024 Entera Phase 2 Osteoporosis Paper in JBMR
  • 2023 ASBMR Poster 1
  • 2023 ASBMR Poster 2
  • 2022 ASBMR Poster

Hypoparathyroidism

  • 2024 ENDO Poster
  • 2021 June, Entera Hypo Paper in JBMR
  • 2019 ASBMR Poster

Platform
Technology

  • The Combined Effect of Permeation Enhancement and Proteolysis Inhibition on the Systemic Exposure of Orally Administrated Peptides

Other Targets

  • Oral Delivery Technology Enabling Gastro-Mucosal Absorption of Glucagon-Like-Peptide-2 Analog (Teduglutide) - A Novel Approach for Injection-Free Treatment of Short Bowel Syndrome
  • Hadassah Bio Park, 5th Floor | Jerusalem Israel 9112002
  • info@enterabio.com
  • Home
  • About us
  • Technology
  • Pipeline
  • Investors & Media
  • Contact Us
  • Accessibility Statement
© 2025 EnteraBio Ltd.
Privacy Policy
A-2-Z - Digital Accessibility and Marketing